Perfromance Wealth Partners »

Revance Therapeutics shares owned by Perfromance Wealth Partners

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Perfromance Wealth Partners from 13F filings

Historical chart of Perfromance Wealth Partners investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Perfromance Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Perfromance Wealth Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $81k 17k 4.92
2023-09-30 $212k 19k 11.47
2023-06-30 $457k 19k 24.72
2023-03-31 $499k 16k 32.21
2022-12-31 $240k 13k 18.46
2022-09-30 $351k 13k 27.00
2022-06-30 $180k 13k 13.85
2022-03-31 $254k 13k 19.54
2021-12-31 $212k 13k 16.31